Mark Sullivan, MD, PhD

Personal Statement

My clinical service and research focuses on the interaction of mental and physical illness, especially in patients with chronic pain. Much of my research in recent decades has focused on the risks of treating chronic pain with opioids. I have developed educational programs and outcome tracking tools to assist with opioid treatment of chronic pain. I have published a book about patient empowerment in chronic disease care, The Patient as Agent of Health and Health Care (Oxford, 2017). I have another book written with Jane Ballantyne forthcoming, The Right to Pain Relief and other deep roots of the opioid epidemic (Oxford, 2022).


Vanderbilt Univ. Sch. of Medicine Medical education, 1984
Univ. of Missouri Columbia Internship, Family Medicine
UW - Dept. of Psychiatry & Behavioral Sciences Residency, Psychiatry

Department Affiliations

Other Affiliations

UWMC Center for Pain Relief

Teaching Philosophy

​I like to have trainees manage patients under my supervision. Trainees need real responsibility to learn and develop management skills.
In didactic sessions, I strive for interaction between myself and trainees. I generally teach in a seminar format centered around case presentations. I expect all trainees to contribute to the discussion and the learning of others.

Recent Publications

"I really had somebody in my corner." Patient experiences with a pharmacist-led opioid tapering program.
(2022 May 26)
J Am Pharm Assoc (2003)
Schneider JL, Firemark AJ, Papajorgji-Taylor D, Reese KR, Thorsness LA, Sullivan MD, DeBar LL, Smith DH, Kuntz JL

Detection of selective androgen receptor modulators (SARMs) in serum using a molecularly imprinted nanoparticle surface plasmon resonance sensor.
(2022 Jun 9)
J Mater Chem B
Henderson A, Sullivan MV, Hand RA, Turner NW

Is Chronic Pain a Disease?
(2022 May 13)
J Pain
Ballantyne JC, Sullivan MD

Stabilizing the pharmacy technician workforce as an imperative for the chief pharmacy officer.
(2022 May 10)
Am J Health Syst Pharm
Rewald M, Woller TW, Sullivan M

Reply to Fields and Darnall.
(2022 May 1)
Pain 163(5): e690-e691
Sullivan MD

Show complete publication list »
Edit Profile